Biography
Dr Paulo Emilio Feuser completed a degree in pharmacology from the Universidade do Extremo Sul Catarinense in 2006, qualification in industry from the Universidade Tuiuti do Paraná in 2008, specialization in industrial pharmaceutical technology from the Federal University of Rio de Janeiro in 2009 and a masters and doctorate in chemical engineering from the Federal University of Santa Catarina (UFSC) from 2010 to 2016. Paulo has experience in the field of polymers, biomaterials, nanotechnology/nanobiotechnology, preparation and characterization of biomaterials, pharmacotechnics, drug quality control and cell biology (cancer). He is currently a postdoctoral fellow in chemical engineering at UFSC, working in the field of nanobiotechnology (drug delivery systems - controlled release) and co-founder of startup PeptNano – Personalized Services in Biotechnology.
Research interests: diagnosis; peptides; nanotechnology
Collaboration ideas: I work with Professor Ricardo, who is the head of a research group in UNESC, a community university located in the south of Brazil. His research topics involve, mainly, bioinformatics, peptides, and nanotechnology, combined or not.
He has been working on these topics since 2000 when he initiated his graduation in chemistry and then, his PhD in bioinformatics. The focus of his research was about animal venoms, but in the last years, he has been collaborating with several other projects. Using bioinformatics and peptides, we are cooperating in the development of diagnosis of different diseases, such as malaria, Zyca, dengue, chagas, leishmaniasis, leprosy COVID-19 and other ones. Furthermore, a lot of work has been done in the creation of new vaccines and treatments for several diseases.
Besides that, recombinant chimeric proteins using predicted epitopes were produced to develop new diagnosis, vaccines, and serum to prevent and treat human and canine leishmaniasis and envenomation by spiders, scorpions, and snakes.
In addition to bioinformatics and peptides, we have been working with lipid, metallic, polymeric, and magnetic nanoparticles, using them in all kinds of situations. Metallic nanoparticles are being used to treat different conditions, as Parkinson’s disease, cancer, wound healing and leishmaniasis. The metallic ones were used to improve the diagnosis of COVID-19 using peptides as antigen.
Therefore, adding the expertise in different techniques and the possibility to work in a large variety of fields, we expect to create a partnership to educate new students, collaborate in different projects and learn new techniques to use in our laboratory.
ORCID ID: 0000-0003-2372-8945
Research ID: D-3202-2018